Parian Ultreia LP - 22 May 2026 SCHEDULE 13G Report for EXAGEN INC. Exagen, Inc. (XGN)

Filing manager: Parian Ultreia LP
Reporting owner: Parian Ultreia LP
Security: EXAGEN INC. Exagen, Inc.
Beneficially owned shares: 1,292,000 shares
Large-stake signal: Form
SCHEDULE 13G
Passive or exempt beneficial ownership filing.
Ownership
5.3%
Beneficial ownership of this reported class.
Shares
1,292,000 shares
Shares beneficially owned as disclosed.
Event date
22 May 2026
Date tied to the ownership event or amendment.
Accepted by SEC
27 May 2026
EDGAR acceptance date.
How to read this large-stake filing
Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
Compare this filing with the holder history and issuer page before treating the percentage as a current position.
Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Class ownership: 5.3%
Symbol: XGN
Shares outstanding: 24,377,358 shares
Form type: SCHEDULE 13G
Accepted by SEC: 27 May 2026, 12:33:18 UTC
Event date: 22 May 2026
SEC filing: View source filing

Key filing fact

Parian Ultreia LP disclosed 5.3% ownership in EXAGEN INC. Exagen, Inc. (XGN) on 22 May 2026.

Key facts

This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares owned	Sole voting power	Shared voting power	Signature	Title	CIK
Parian Ultreia LP	5.3%	1,292,000	1,292,000	0	Zach Miller	Portfolio Manager

CIK / CUSIP context first

Broader feeds